DOCSLIB.ORG

Leukocyte Attraction Macrophages with Distinct Changes in Adaptive

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Leukocyte Attraction Macrophages with Distinct Changes in Adaptive Chronic Exposure to Glucocorticoids Shapes Gene Expression and Modulates Innate and Adaptive Activation Pathways in Macrophages with Distinct Changes in This information is current as Leukocyte Attraction of September 28, 2021. Martijn D. B. van de Garde, Fernando O. Martinez, Barbro N. Melgert, Machteld N. Hylkema, René E. Jonkers and Jörg Hamann J Immunol 2014; 192:1196-1208; Prepublished online 6 Downloaded from January 2014; doi: 10.4049/jimmunol.1302138 http://www.jimmunol.org/content/192/3/1196 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2014/01/05/jimmunol.130213 Material 8.DCSupplemental References This article cites 56 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/192/3/1196.full#ref-list-1 by guest on September 28, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Chronic Exposure to Glucocorticoids Shapes Gene Expression and Modulates Innate and Adaptive Activation Pathways in Macrophages with Distinct Changes in Leukocyte Attraction Martijn D. B. van de Garde,*,1 Fernando O. Martinez,†,1 Barbro N. Melgert,‡,x || Machteld N. Hylkema,x,{ Rene´ E. Jonkers, and Jo¨rg Hamann* Glucocorticoids (GCs) have been used for more than 50 y as immunosuppressive drugs, yet their efficacy in macrophage-dominated disorders, such as chronic obstructive pulmonary disease, is debated. Little is known how long-term GC treatment affects macrophage responses in inflammatory conditions. In this study, we compared the transcriptome of human macrophages, matured in the presence or absence of fluticasone propionate (FP), and their ability to initiate or sustain classical activation, mimicked using acute LPS and chronic IFN-g stimulation, respectively. We identified macrophage gene expression networks, modulated by FP long-term exposure, Downloaded from and specific patterns of IFN-g– and LPS-induced genes that were resistant, inhibited, or exacerbated by FP. Results suggest that long-term treatment with GCs weakens adaptive immune signature components of IFN-g and LPS gene profiles by downmodulating MHC class II and costimulatory molecules, but strengthens innate signature components by maintaining and increasing expression of chemokines involved in phagocyte attraction. In a mouse model of chronic obstructive pulmonary disease, GC treatment induced higher chemokine levels, and this correlated with enhanced recruitment of leukocytes. Thus, GCs do not generally suppress macrophage effector functions, but they cause a shift in the innate–adaptive balance of the immune response, with distinct changes http://www.jimmunol.org/ in the chemokine–chemokine receptor network. The Journal of Immunology, 2014, 192: 1196–1208. acrophages are innate immune cells with well-established of a developing concept: macrophage plasticity (3). Plasticity is roles in tissue homeostasis, primary response to patho- naturally the basis of macrophage heterogeneity in basal and M gens, coordination of adaptive immunity, and even wound inflammatory conditions; it is also the basis of worldwide efforts repair (1, 2). Macrophages accomplish these varied roles by adapting to treat diseases by subverting aberrant macrophage activation. their gene and protein expression programs in response to endoge- Macrophage-mediated inflammation is increasingly recognized nous and exogenous environmental cues, such as cytokines and as contributing to chronic inflammatory disorders, such as chronic pathogen-associated molecular patterns. The ability of macrophages obstructive pulmonary disease (COPD), severe asthma, rheumatoid by guest on September 28, 2021 to change their gene and protein signatures falls under the umbrella arthritis, and multiple sclerosis (4). The best-characterized macrophage activation pathway has been called classical macrophage activation, and it is triggered by *Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; †Sir William Dunn School of the recognition of pathogen-associated molecular patterns by TLRs, Pathology and Kennedy Institute of Rheumatology, University of Oxford, Oxford supported by further elicitation of IFN pathways (2). Classically ‡ OX1 3RE, United Kingdom; Department of Pharmacokinetics, Toxicology and activated macrophages produce microbicidal enzymes, such as Targeting, Groningen Research Institute for Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands; xGroningen Research Institute for Asthma inducible NO synthase, inflammatory cytokines, such as TNF, IL-6, and COPD, University Medical Center Groningen, University of Groningen, IL-1b,IL-12,andIFN-b, various chemoattractants, and matrix 9713 GZ Groningen, The Netherlands; {Department of Pathology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The metallopeptidases (MMPs). These mediators support IFN-g–mediated Netherlands; and ||Department of Pulmonology, Academic Medical Center, University Th1 responses, which are important for sustained antimicrobial of Amsterdam, 1105 AZ Amsterdam, The Netherlands activity but are deleterious in chronic diseases, because they lead to 1 M.D.B.v.d.G. and F.O.M. contributed equally to this work. tissue damage and chronic inflammation. Received for publication August 14, 2013. Accepted for publication November 25, To limit macrophage activation and restore homeostasis, endog- 2013. enous glucocorticoids (GCs) induce anti-inflammatory programs via This work was supported by a grant from the J.K. de Cock Stichting and Prof. Dirkje Postma through a Spinoza grant from the Dutch Government. the GC receptor (GCR) (5, 6). GCR agonists are prescribed for a wide range of inflammatory disorders, and their use is crucial to Address correspondence and reprint requests to Dr. Fernando O. Martinez or Dr. Jo¨rg Hamann, Kennedy Rheumatology Institute, Nuffield Department of Orthopaedics, treat diseases of the respiratory tract, especially asthma (6). Drugs Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University such as prednisolone, dexamethasone, budesonide, and fluticasone of Oxford, Windmill Road, Headington, Oxford, OX37 LD, U.K. (F.O.M.) or De- partment of Experimental Immunology, Academic Medical Center, University of propionate (FP) share great GCR specificity albeit different phar- Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands (J.H.). E-mail macodynamics (7). The remarkable efficacy of GCs in suppressing addresses: [email protected] (F.O.M.) or j.hamann@amc. uva.nl (J.H.) inflammation and decreasing lymphocyte activation, proliferation, The online version of this article contains supplemental material. and survival is well appreciated. However, our knowledge of the interactions of GC and inflammatory pathways in human mac- Abbreviations used in this article: COPD, chronic obstructive pulmonary disease; FP, fluticasone propionate; GC, glucocorticoid; GCR, GC receptor; IPA, Ingenuity Path- rophages remains limited (8), and recent studies have shown that GCs ways Analysis; MDM, monocyte-derived macrophage; MEV, Multiple Experiment may have little effect in controlling inflammation in macrophage- Viewer; MMP, matrix metalloproteinase. dominated diseases, and their long-term use is associated with Copyright Ó 2014 by The American Association of Immunologists, Inc. 0022-1767/14/$16.00 persisting complications (9–16). www.jimmunol.org/cgi/doi/10.4049/jimmunol.1302138 The Journal of Immunology 1197 In this study, we investigated from a whole genome point of view study we focused our analysis on data generated on human cells backed the effects of chronic GCR ligation on the maturation of human up by experimental evidence. Data compliant for Minimum Information macrophages and on their ability to initiate and sustain classical About a Microarray Experiment for the datasets used in this study are deposited in Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) pro- activation that is important for Th1 inflammation, dissected by files dataset GSE49852. This dataset is part of a superseries—GSE35495— acute and chronic stimulation with the TLR4 ligand LPS and IFN-g. that covers microarrays over the spectrum of macrophage activation, in- We show that long-term treatment with FP modulates classical cluding IFN-g, IL-4, IL-10, IL-13, and dexamethasone (18). activation in human inflammatory macrophage models in a com- For comparison, CEL files generated by Ehrchen et al. (19) in a microarray analysis of monocytes stimulated with FP for 16 h were summarized as plex and not solely suppressive manner by maintaining or even Robust Multiarray Averaging, and quantiles were normalized using Affy increasing the expression of chemokines
Load more

Recommended publications
  • Variation in FCN1 Affects Biosynthesis of Ficolin-1 and Is Associated With
    Genes and Immunity (2012) 13, 515–522 & 2012 Macmillan Publishers Limited All rights reserved 1466-4879/12 www.nature.com/gene ORIGINAL ARTICLE Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation L Munthe-Fog1, T Hummelshoj1, C Honore´ 1, ME Moller1, MO Skjoedt1, I Palsgaard1, N Borregaard2, HO Madsen1 and P Garred1 Ficolin-1 is a recognition molecule of the lectin complement pathway. The ficolin-1 gene FCN1 is polymorphic, but the functional and clinical consequences are unknown.The concentration of ficolin-1 in plasma and FCN1 polymorphisms in positions À 1981 (rs2989727), À 791 (rs28909068), À 542 (rs10120023), À 271 (rs28909976), À 144 (rs10117466) and þ 7918 (rs1071583) were determined in 100 healthy individuals. FCN1 expression by isolated monocytes and granulocytes and ficolin-1 levels in monocyte culture supernatants were assessed in 21 FCN1-genotyped individuals. FCN1 polymorphisms were determined in a cohort of 251 patients with systemic inflammation. High ficolin-1 plasma levels were significantly associated with the minor alleles in position À 542 and À 144. These alleles were also significantly associated with high FCN1 mRNA expression. The level of ficolin-1 in culture supernatants was significantly higher in individuals homozygous for the minor alleles at positions À 542 and À 144. Homozygosity for these alleles was significantly associated with fatal outcome in patients with systemic inflammation. None of the other investigated polymorphisms were associated with FCN1 and ficolin-1 expression, concentration or disease outcome. Functional polymorphic sites in the promoter region of FCN1 regulate both the expression and synthesis of ficolin-1 and are associated with outcome in severe inflammation.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Figure S1. Representative Report Generated by the Ion Torrent System Server for Each of the KCC71 Panel Analysis and Pcafusion Analysis
    Figure S1. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. A Figure S1. Continued. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. B Figure S2. Comparative analysis of the variant frequency found by the KCC71 panel and calculated from publicly available cBioPortal datasets. For each of the 71 genes in the KCC71 panel, the frequency of variants was calculated as the variant number found in the examined cases. Datasets marked with different colors and sample numbers of prostate cancer are presented in the upper right. *Significantly high in the present study. Figure S3. Seven subnetworks extracted from each of seven public prostate cancer gene networks in TCNG (Table SVI). Blue dots represent genes that include initial seed genes (parent nodes), and parent‑child and child‑grandchild genes in the network. Graphical representation of node‑to‑node associations and subnetwork structures that differed among and were unique to each of the seven subnetworks. TCNG, The Cancer Network Galaxy. Figure S4. REVIGO tree map showing the predicted biological processes of prostate cancer in the Japanese. Each rectangle represents a biological function in terms of a Gene Ontology (GO) term, with the size adjusted to represent the P‑value of the GO term in the underlying GO term database.
    [Show full text]
  • An Investigation of ADAM-Like Decysin 1 in Macrophage-Mediated Inflammation and Crohn’S Disease
    An Investigation of ADAM-like Decysin 1 in Macrophage-mediated Inflammation and Crohn’s Disease By Nuala Roisin O’Shea A thesis submitted to UCL for the degree of Doctor of Philosophy Division of Medicine Declaration I, Nuala Roisin O’Shea, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Crohn’s disease (CD) is now recognised as a defective host response to bacteria in genetically susceptible individuals. The role of innate immunity and impaired bacterial clearance are widely accepted. In this thesis the role of ADAM-like, Decysin-1 (ADAMDEC1) in macrophage-mediated inflammation and gut mucosal immunity is explored. Using transcriptomic analysis of monocyte derived macrophages (MDM) ADAMDEC1 was identified as grossly under expressed in a subset of patients with CD. ADAMDEC1 was found to be highly selective to the intestine, peripheral blood monocyte-derived and lamina propria macrophages. It was shown to be an inflammatory response gene, upregulated in response to bacterial antigens and inflammation. ADAMDEC1 was expressed in prenatal and germ free mice, demonstrating exposure to a bacterial antigen is not a prerequisite for expression. Adamdec1 knock out mice were used to investigate the role of ADAMDEC1 in vivo. Adamdec1-/- mice displayed an increased susceptibility to dextran sodium sulphate (DSS), Citrobacter rodentium and Salmonella typhimurium induced colitis. In Adamdec1-/- mice, bacterial translocation and systemic infection were increased in bacterial models of colitis. These results suggest that individuals with grossly attenuated expression of ADAMDEC1 may be at an increased risk of developing intestinal inflammation as a consequence of an impaired ability to handle enteric bacterial pathogens.
    [Show full text]
  • Proteomic Analysis of Human Osteoarthritis Synovial Fluid
    Balakrishnan et al. Clinical Proteomics 2014, 11:6 http://www.clinicalproteomicsjournal.com/content/11/1/6 CLINICAL PROTEOMICS RESEARCH Open Access Proteomic analysis of human osteoarthritis synovial fluid Lavanya Balakrishnan1,2, Raja Sekhar Nirujogi1,3, Sartaj Ahmad1,4, Mitali Bhattacharjee1,5, Srikanth S Manda1,3, Santosh Renuse1,5, Dhanashree S Kelkar1,5, Yashwanth Subbannayya1,6, Rajesh Raju1, Renu Goel1,2, Joji Kurian Thomas1,5, Navjyot Kaur7, Mukesh Dhillon7, Shantal Gupta Tankala7, Ramesh Jois8, Vivek Vasdev9, YL Ramachandra2, Nandini A Sahasrabuddhe1, TS Keshava Prasad1,3,4, Sujatha Mohan10, Harsha Gowda1, Subramanian Shankar7* and Akhilesh Pandey11,12,13,14* Abstract Background: Osteoarthritis is a chronic musculoskeletal disorder characterized mainly by progressive degradation of the hyaline cartilage. Patients with osteoarthritis often postpone seeking medical help, which results in the diagnosis being made at an advanced stage of cartilage destruction. Sustained efforts are needed to identify specific markers that might help in early diagnosis, monitoring disease progression and in improving therapeutic outcomes. We employed a multipronged proteomic approach, which included multiple fractionation strategies followed by high resolution mass spectrometry analysis to explore the proteome of synovial fluid obtained from osteoarthritis patients. In addition to the total proteome, we also enriched glycoproteins from synovial fluid using lectin affinity chromatography. Results: We identified 677 proteins from synovial fluid of patients
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown Et Al
    US 20030082511A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown et al. (43) Pub. Date: May 1, 2003 (54) IDENTIFICATION OF MODULATORY Publication Classification MOLECULES USING INDUCIBLE PROMOTERS (51) Int. Cl." ............................... C12O 1/00; C12O 1/68 (52) U.S. Cl. ..................................................... 435/4; 435/6 (76) Inventors: Steven J. Brown, San Diego, CA (US); Damien J. Dunnington, San Diego, CA (US); Imran Clark, San Diego, CA (57) ABSTRACT (US) Correspondence Address: Methods for identifying an ion channel modulator, a target David B. Waller & Associates membrane receptor modulator molecule, and other modula 5677 Oberlin Drive tory molecules are disclosed, as well as cells and vectors for Suit 214 use in those methods. A polynucleotide encoding target is San Diego, CA 92121 (US) provided in a cell under control of an inducible promoter, and candidate modulatory molecules are contacted with the (21) Appl. No.: 09/965,201 cell after induction of the promoter to ascertain whether a change in a measurable physiological parameter occurs as a (22) Filed: Sep. 25, 2001 result of the candidate modulatory molecule. Patent Application Publication May 1, 2003 Sheet 1 of 8 US 2003/0082511 A1 KCNC1 cDNA F.G. 1 Patent Application Publication May 1, 2003 Sheet 2 of 8 US 2003/0082511 A1 49 - -9 G C EH H EH N t R M h so as se W M M MP N FIG.2 Patent Application Publication May 1, 2003 Sheet 3 of 8 US 2003/0082511 A1 FG. 3 Patent Application Publication May 1, 2003 Sheet 4 of 8 US 2003/0082511 A1 KCNC1 ITREXCHO KC 150 mM KC 2000000 so 100 mM induced Uninduced Steady state O 100 200 300 400 500 600 700 Time (seconds) FIG.
    [Show full text]
  • Anti-RNASE1 (GW10801F)
    Anti-RNASE1 antibody produced in chicken, affinity isolated antibody Catalog Number GW10801F Formerly listed as GenWay Catalog Number 15-288- 10801F, Ribonuclease pancreatic Antibody. Storage Temperature –20 °C EC 3.1.27.5 Precautions and Disclaimer Synonyms: Pancreatic ribonuclease; RNase 1; This product is for R&D use only, not for drug, RNase A; RNase UpI-1; RIB-1; HP-RNase household, or other uses. Due to the sodium azide content a material safety data sheet (MSDS) for this Product Description product has been sent to the attention of the safety Endonuclease that catalyzes the cleavage of RNA on officer of your institution. Please consult the Material the 3¢ side of pyrimidine nucleotides. Acts on single Safety Data Sheet for information regarding hazards stranded and double stranded RNA. and safe handling practices. NCBI Accession number: NP_002924.1 Storage/Stability Swiss Prot Accession number: P07998 For continuous use, store at 2–8 °C for up to one week. For extended storage, store in –20 °C freezer in Gene Information: Human .. RNASE1 (6035) working aliquots. Repeated freezing and thawing, or storage in “frostfree” freezers, is not recommended. If Immunogen: Recombinant protein Pancreatic slight turbidity occurs upon prolonged storage, clarify ribonuclease the solution by centrifugation before use. Working dilution samples should be discarded if not used within Immunogen Sequence: Gi # 4506547, sequence 1–156 12 hours. The product is a clear, colorless solution in phosphate TD,LPG,MAM 04/09-1 buffered saline, pH 7.2, containing 0.02% sodium azide. Species Reactivity: Human Tested Applications: WB Recommended Dilutions: Recommended starting dilution for Western blot analysis is 1:500 for tissue or cell staining 1:200.
    [Show full text]
  • Human Lectins, Their Carbohydrate Affinities and Where to Find Them
    biomolecules Review Human Lectins, Their Carbohydrate Affinities and Where to Review HumanFind Them Lectins, Their Carbohydrate Affinities and Where to FindCláudia ThemD. Raposo 1,*, André B. Canelas 2 and M. Teresa Barros 1 1, 2 1 Cláudia D. Raposo * , Andr1 é LAQVB. Canelas‐Requimte,and Department M. Teresa of Chemistry, Barros NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829‐516 Caparica, Portugal; [email protected] 12 GlanbiaLAQV-Requimte,‐AgriChemWhey, Department Lisheen of Chemistry, Mine, Killoran, NOVA Moyne, School E41 of ScienceR622 Co. and Tipperary, Technology, Ireland; canelas‐ [email protected] NOVA de Lisboa, 2829-516 Caparica, Portugal; [email protected] 2* Correspondence:Glanbia-AgriChemWhey, [email protected]; Lisheen Mine, Tel.: Killoran, +351‐212948550 Moyne, E41 R622 Tipperary, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +351-212948550 Abstract: Lectins are a class of proteins responsible for several biological roles such as cell‐cell in‐ Abstract:teractions,Lectins signaling are pathways, a class of and proteins several responsible innate immune for several responses biological against roles pathogens. such as Since cell-cell lec‐ interactions,tins are able signalingto bind to pathways, carbohydrates, and several they can innate be a immuneviable target responses for targeted against drug pathogens. delivery Since sys‐ lectinstems. In are fact, able several to bind lectins to carbohydrates, were approved they by canFood be and a viable Drug targetAdministration for targeted for drugthat purpose. delivery systems.Information In fact, about several specific lectins carbohydrate were approved recognition by Food by andlectin Drug receptors Administration was gathered for that herein, purpose. plus Informationthe specific organs about specific where those carbohydrate lectins can recognition be found by within lectin the receptors human was body.
    [Show full text]
  • Adiponectin and Related C1q/TNF-Related Proteins Bind Selectively to Anionic Phospholipids and Sphingolipids
    Adiponectin and related C1q/TNF-related proteins bind selectively to anionic phospholipids and sphingolipids Jessica J. Yea,b, Xin Bianc,d, Jaechul Lima,b, and Ruslan Medzhitova,b,1 aHHMI, Yale University, New Haven, CT 06520; bDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520; cDepartment of Cell Biology, Yale University School of Medicine, New Haven, CT 06520; and dDepartment of Neuroscience, Yale University School of Medicine, New Haven, CT 06520 Contributed by Ruslan Medzhitov, April 14, 2020 (sent for review December 20, 2019; reviewed by Ido Amit and G. William Wong) Adiponectin (Acrp30) is an adipokine associated with protection 5-mers of trimers, respectively referred to as low molecular weight from cardiovascular disease, insulin resistance, and inflammation. (LMW), medium molecular weight (MMW), and high molecular Although its effects are conventionally attributed to binding weight (HMW) complexes. Adiponectin can also be cleaved by Adipor1/2 and T-cadherin, its abundance in circulation, role in serum elastases and thrombin between the globular C1q-like head ceramide metabolism, and homology to C1q suggest an overlooked domain and the collagenous tail domain, forming globular adi- role as a lipid-binding protein, possibly generalizable to other C1q/ ponectin (gAd). While gAd appears to bind AdipoR1/2 and ac- TNF-related proteins (CTRPs) and C1q family members. To investi- tivate AMPK more strongly than full-length protein (19, 20), levels gate this, adiponectin, representative family members, and variants of HMW multimers are more strongly associated with insulin were expressed in Expi293 cells and tested for binding to lipids in sensitivity (21, 22), have a longer half-life in circulation (18), and liposomes using density centrifugation.
    [Show full text]
  • Microarray Analysis of Novel Genes Involved in HSV- 2 Infection
    Microarray analysis of novel genes involved in HSV- 2 infection Hao Zhang Nanjing University of Chinese Medicine Tao Liu ( [email protected] ) Nanjing University of Chinese Medicine https://orcid.org/0000-0002-7654-2995 Research Article Keywords: HSV-2 infection,Microarray analysis,Histospecic gene expression Posted Date: May 12th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-517057/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/19 Abstract Background: Herpes simplex virus type 2 infects the body and becomes an incurable and recurring disease. The pathogenesis of HSV-2 infection is not completely clear. Methods: We analyze the GSE18527 dataset in the GEO database in this paper to obtain distinctively displayed genes(DDGs)in the total sequential RNA of the biopsies of normal and lesioned skin groups, healed skin and lesioned skin groups of genital herpes patients, respectively.The related data of 3 cases of normal skin group, 4 cases of lesioned group and 6 cases of healed group were analyzed.The histospecic gene analysis , functional enrichment and protein interaction network analysis of the differential genes were also performed, and the critical components were selected. Results: 40 up-regulated genes and 43 down-regulated genes were isolated by differential performance assay. Histospecic gene analysis of DDGs suggested that the most abundant system for gene expression was the skin, immune system and the nervous system.Through the construction of core gene combinations, protein interaction network analysis and selection of histospecic distribution genes, 17 associated genes were selected CXCL10,MX1,ISG15,IFIT1,IFIT3,IFIT2,OASL,ISG20,RSAD2,GBP1,IFI44L,DDX58,USP18,CXCL11,GBP5,GBP4 and CXCL9.The above genes are mainly located in the skin, immune system, nervous system and reproductive system.
    [Show full text]
  • Analysis of Dynamic Molecular Networks for Pancreatic Ductal
    Pan et al. Cancer Cell Int (2018) 18:214 https://doi.org/10.1186/s12935-018-0718-5 Cancer Cell International PRIMARY RESEARCH Open Access Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression Zongfu Pan1†, Lu Li2†, Qilu Fang1, Yiwen Zhang1, Xiaoping Hu1, Yangyang Qian3 and Ping Huang1* Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid tumors. The rapid progression of PDAC results in an advanced stage of patients when diagnosed. However, the dynamic molecular mechanism underlying PDAC progression remains far from clear. Methods: The microarray GSE62165 containing PDAC staging samples was obtained from Gene Expression Omnibus and the diferentially expressed genes (DEGs) between normal tissue and PDAC of diferent stages were profled using R software, respectively. The software program Short Time-series Expression Miner was applied to cluster, compare, and visualize gene expression diferences between PDAC stages. Then, function annotation and pathway enrichment of DEGs were conducted by Database for Annotation Visualization and Integrated Discovery. Further, the Cytoscape plugin DyNetViewer was applied to construct the dynamic protein–protein interaction networks and to analyze dif- ferent topological variation of nodes and clusters over time. The phosphosite markers of stage-specifc protein kinases were predicted by PhosphoSitePlus database. Moreover, survival analysis of candidate genes and pathways was per- formed by Kaplan–Meier plotter. Finally, candidate genes were validated by immunohistochemistry in PDAC tissues. Results: Compared with normal tissues, the total DEGs number for each PDAC stage were 994 (stage I), 967 (stage IIa), 965 (stage IIb), 1027 (stage III), 925 (stage IV), respectively. The stage-course gene expression analysis showed that 30 distinct expressional models were clustered.
    [Show full text]
  • Title:​Ribosome Clearance During RNA Interference
    Downloaded from rnajournal.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press Pule, 1 Title: Ribosome clearance during RNA interference ​ 1 1 2 1 Authors: Makena N. Pule ,​ Marissa L. Glover ,​ Andrew Z. Fire ,​ Joshua A. Arribere ​ ​ ​ ​ ​ Short Title: Ribosome clearance during RNA interference ​ Keywords: SKI, PELOTA, RNAi, C. elegans, ribosome, nonstop ​ 1 Department​ of MCD Biology, UC Santa Cruz 2 Departments​ of Pathology and Genetics, Stanford University School of Medicine Downloaded from rnajournal.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press Pule, 2 ABSTRACT In the course of identifying and cleaving RNA, the RNAi machinery must encounter and contend with the megadalton-sized ribosomes that carry out translation. We investigated this interface by examining the fate of actively translated mRNAs subjected to RNAi in C. elegans. Quantifying ​ ​ RNA levels (RNA-seq) and ongoing translation (Ribo-seq), we found there is a greater fold repression of ongoing translation than expected from loss of RNA alone, observing stronger translation repression relative to RNA repression for multiple, independent double-stranded RNA triggers, and for multiple genes. In animals that lack the RNA helicase SKI complex and the ribosome rescue factor PELOTA, ribosomes stall on the 3’ edges of mRNAs at and upstream of the RNAi trigger. One model to explain these observations is that ribosomes are actively cleared from mRNAs by SKI and PELO during or following mRNA cleavage. Our results expand prior studies that show a role for the SKI RNA helicase complex in removing RNA targets following RNAi in flies and plants, illuminating the widespread role of the nonstop translation surveillance in RNA silencing during RNAi.
    [Show full text]